Lineage-tracing hematopoietic stem cell origins in vivo to efficiently make human HLF+ HOXA+ hematopoietic progenitors from pluripotent stem cells

Autor: Fowler, Jonas L., Zheng, Sherry Li, Nguyen, Alana, Chen, Angela, Xiong, Xiaochen, Chai, Timothy, Chen, Julie Y., Karigane, Daiki, Banuelos, Allison M., Niizuma, Kouta, Kayamori, Kensuke, Nishimura, Toshinobu, Cromer, M. Kyle, Gonzalez-Perez, David, Mason, Charlotte, Liu, Daniel Dan, Yilmaz, Leyla, Miquerol, Lucile, Porteus, Matthew H., Luca, Vincent C., Majeti, Ravindra, Nakauchi, Hiromitsu, Red-Horse, Kristy, Weissman, Irving L., Ang, Lay Teng, Loh, Kyle M.

Publikováno v: In Developmental Cell 6 May 2024 59(9):1110-1131

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prospective isolation of neural stem and progenitor cells from the developing human brain

Autor: Liu, Daniel Dan, He, Joy Q., Uchida, Nobuko, Weissman, Irving L., Sinha, Rahul

Publikováno v: In STAR Protocols 15 December 2023 4(4)

LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer.

Autor: Pérez-Núñez I; Cancer Research Program, Hospital del Mar Medical Research Institute, Barcelona, Spain., Rozalén C; Cancer Research Program, Hospital del Mar Medical Research Institute, Barcelona, Spain., Palomeque JÁ; Cancer Research Program, Hospital del Mar Medical Research Institute, Barcelona, Spain., Sangrador I; Cancer Research Program, Hospital del Mar Medical Research Institute, Barcelona, Spain., Dalmau M; Cancer Research Program, Hospital del Mar Medical Research Institute, Barcelona, Spain., Comerma L; Pathology Department, Hospital del Mar, Barcelona, Spain., Hernández-Prat A; Cancer Research Program, Hospital del Mar Medical Research Institute, Barcelona, Spain., Casadevall D; Cancer Research Program, Hospital del Mar Medical Research Institute, Barcelona, Spain., Menendez S; Cancer Research Program, Hospital del Mar Medical Research Institute, Barcelona, Spain., Liu DD; Department of Molecular Biology, Princeton University, Princeton, NJ, USA.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA., Shen M; Department of Molecular Biology, Princeton University, Princeton, NJ, USA., Berenguer J; Cancer Research Program, Hospital del Mar Medical Research Institute, Barcelona, Spain., Ruiz IR; Preclinical Research Program, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Peña R; Cancer Research Program, Hospital del Mar Medical Research Institute, Barcelona, Spain., Montañés JC; Research Program on Biomedical Informatics, Hospital del Mar Medical Research Institute and Universitat Pompeu Fabra, Barcelona, Spain., Albà MM; Research Program on Biomedical Informatics, Hospital del Mar Medical Research Institute and Universitat Pompeu Fabra, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain., Bonnin S; Centre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona, Spain., Ponomarenko J; Centre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona, Spain.; Universitat Pompeu Fabra, Barcelona, Spain., Gomis RR; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain.; Cancer Science Program, Institute for Research in Biomedicine, The Barcelona Institute of Science and Technology, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Oncología, Madrid, Spain., Cejalvo JM; Centro de Investigación Biomédica en Red de Oncología, Madrid, Spain.; Medical Oncology Department, Hospital Clínico Universitario; Medicine Department, Universidad de Valencia, Spain, INCLIVA, Valencia, Spain., Servitja S; Centro de Investigación Biomédica en Red de Oncología, Madrid, Spain.; Medical Oncology Department, Hospital del Mar, Barcelona, Spain., Marzese DM; Fundació Institut d'Investigació Sanitària Illes Balears, Mallorca, Spain., Morey L; Sylvester Comprehensive Cancer Center, Miami, FL, USA.; Department of Human Genetics, University of Miami Miller School of Medicine, Miami, FL, USA., Voorwerk L; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Arribas J; Cancer Research Program, Hospital del Mar Medical Research Institute, Barcelona, Spain.; Preclinical Research Program, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Oncología, Madrid, Spain., Bermejo B; Centro de Investigación Biomédica en Red de Oncología, Madrid, Spain.; Medical Oncology Department, Hospital Clínico Universitario; Medicine Department, Universidad de Valencia, Spain, INCLIVA, Valencia, Spain., Kok M; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Pusztai L; Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA., Kang Y; Department of Molecular Biology, Princeton University, Princeton, NJ, USA.; Ludwig Institute for Cancer Research Princeton Branch, Princeton, NJ, USA., Albanell J; Cancer Research Program, Hospital del Mar Medical Research Institute, Barcelona, Spain. jalbanell@hospitaldelmar.cat.; Universitat Pompeu Fabra, Barcelona, Spain. jalbanell@hospitaldelmar.cat.; Centro de Investigación Biomédica en Red de Oncología, Madrid, Spain. jalbanell@hospitaldelmar.cat.; Medical Oncology Department, Hospital del Mar, Barcelona, Spain. jalbanell@hospitaldelmar.cat., Celià-Terrassa T; Cancer Research Program, Hospital del Mar Medical Research Institute, Barcelona, Spain. acelia@imim.es.; Centro de Investigación Biomédica en Red de Oncología, Madrid, Spain. acelia@imim.es.

Publikováno v: Nature cancer [Nat Cancer] 2022 Mar; Vol. 3 (3), pp. 355-370. Date of Electronic Publication: 2022 Mar 17.